(Q33490033)

English

Electrocardiographic left ventricular hypertrophy regression induced by an angiotensin receptor blocker-based regimen in hypertensive patients with diabetes: data from the SARA study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Electrocardiographic left ventricular hypertrophy regression induced by an angiotensin receptor blocker-based regimen in hypertensive patients with diabetes: data from the SARA study (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

electrocardiography

1 reference

based on heuristic

inferred from title

left ventricular hypertrophy

1 reference

based on heuristic

inferred from title

2

object named as

Carlos Escobar

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

author name string

Vivencio Barrios

1

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Alberto Calderón

3

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Rocio Echarri

4

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Sara Barrios

5

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Josefa Navarro-Cid

6

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

publication date

3 August 2009

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Journal of the Renin-Angiotensin-Aldosterone System

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

168-173

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Hypertension and diabetes: a toxic combination

1 reference

https://api.crossref.org/works/10.1177%2F1470320309343596

21 January 2018

Intravenous intralipid-induced blood pressure elevation and endothelial dysfunction in obese African-Americans with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1177%2F1470320309343596

21 January 2018

Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75).

1 reference

https://api.crossref.org/works/10.1177%2F1470320309343596

21 January 2018

2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension

1 reference

https://api.crossref.org/works/10.1177%2F1470320309343596

21 January 2018

Effect of type 2 diabetes mellitus on left ventricular geometry and systolic function in hypertensive subjects: Hypertension Genetic Epidemiology Network (HyperGEN) study

1 reference

https://api.crossref.org/works/10.1177%2F1470320309343596

21 January 2018

Screening for and treating left-ventricular abnormalities in diabetes mellitus: a new way of reducing cardiac deaths

1 reference

https://api.crossref.org/works/10.1177%2F1470320309343596

21 January 2018

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

https://api.crossref.org/works/10.1177%2F1470320309343596

21 January 2018

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

1 reference

https://api.crossref.org/works/10.1177%2F1470320309343596

21 January 2018

2007 Guidelines for the Management of Arterial Hypertension

1 reference

https://api.crossref.org/works/10.1177%2F1470320309343596

21 January 2018

Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events

1 reference

https://api.crossref.org/works/10.1177%2F1470320309343596

21 January 2018

Candesartan cilexetil improves left ventricular function, left ventricular hypertrophy, and endothelial function in patients with hypertensive heart disease

1 reference

https://api.crossref.org/works/10.1177%2F1470320309343596

21 January 2018

Electrocardiographic left ventricular hypertrophy regression induced by an angiotensin receptor blocker-based regimen in daily clinical practice: the SARA study.

1 reference

https://api.crossref.org/works/10.1177%2F1470320309343596

21 January 2018

Electrocardiographic left ventricular hypertrophy regression induced by an angiotensin receptor blocker-based regimen in hypertensive patients with the metabolic syndrome: data from the SARA Study

1 reference

https://api.crossref.org/works/10.1177%2F1470320309343596

21 January 2018

Electrocardiographic detection of left ventricular hypertrophy: development and prospective validation of improved criteria.

1 reference

https://api.crossref.org/works/10.1177%2F1470320309343596

21 January 2018

Time-voltage QRS area of the 12-lead electrocardiogram: detection of left ventricular hypertrophy.

1 reference

https://api.crossref.org/works/10.1177%2F1470320309343596

21 January 2018

New gender-specific partition values for ECG criteria of left ventricular hypertrophy: recalibration against cardiac MRI.

1 reference

https://api.crossref.org/works/10.1177%2F1470320309343596

21 January 2018

Regression of left ventricular hypertrophy by a candesartan-based regimen in clinical practice. The VIPE study.

1 reference

https://api.crossref.org/works/10.1177%2F1470320309343596

21 January 2018

Adverse prognostic significance of new diabetes in treated hypertensive subjects

1 reference

https://api.crossref.org/works/10.1177%2F1470320309343596

21 January 2018

Impact of diabetes mellitus on regression of electrocardiographic left ventricular hypertrophy and the prediction of outcome during antihypertensive therapy: the Losartan Intervention For Endpoint (LIFE) Reduction in Hypertension Study

1 reference

https://api.crossref.org/works/10.1177%2F1470320309343596

21 January 2018

Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (The Framingham Heart Study)

1 reference

https://api.crossref.org/works/10.1177%2F1470320309343596

21 January 2018

Identifiers

10.1177/1470320309343596

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33490033&oldid=1794325706"